Planet 13 Holdings (PLNH) Other Non-Current Assets (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Other Non-Current Assets came in at $898725.0 in Q1 2026, down 80.34% year-on-year from $4.6 million in Q1 2025, and up 8.39% on a QoQ basis from $829164.0 in Q4 2025.
Planet 13 Holdings (PLNH) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Other Non-Current Assets data on file, last reported at $898725.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 80.34% year-over-year to $898725.0 in Q1 2026; TTM through Mar 2026 was $898725.0, a 80.34% decrease from a year earlier, with the FY2025 full-year figure at $829164.0, up 575.0% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $898725.0, up from $829164.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for PLNH reached as high as $9.0 million in Q4 2023 and fell as low as $122839.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $862545.0 in 2022.
- Across the five-year window, Other Non-Current Assets jumped 943.42% in 2023 and plunged 98.64% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $862545.0 in 2022, then soared by 943.42% to $9.0 million in 2023, then plunged by 98.64% to $122839.0 in 2024, then jumped by 575.0% to $829164.0 in 2025, then increased by 8.39% to $898725.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $898725.0 in Q1 2026, $829164.0 in Q4 2025, and $180207.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 898,725.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 898,725.00 |
| Dec 31, 2025 | 829,164.00 |
| Sep 30, 2025 | 180,207.00 |
| Jun 30, 2025 | 266,652.00 |
| Mar 31, 2025 | 4.57 Mn |
| Dec 31, 2024 | 122,839.00 |
| Sep 30, 2024 | 264,431.00 |
| Jun 30, 2024 | 989,376.00 |
| Mar 31, 2024 | 470,256.00 |
| Dec 31, 2023 | 9.00 Mn |
| Sep 30, 2023 | 832,853.00 |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 862,545.00 |
| Dec 31, 2022 | 862,545.00 |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Dec 31, 2021 | 1.06 Mn |